129 related articles for article (PubMed ID: 20970410)
1. Potential implication of aniline derivatives in the Toxic Oil Syndrome (TOS).
Messeguer A
Chem Biol Interact; 2011 Jun; 192(1-2):136-41. PubMed ID: 20970410
[TBL] [Abstract][Full Text] [Related]
2. On the generation and outcome of 3-(N-phenylamino)propane-1,2-diol derivatives in deodorized model oils related to toxic oil syndrome.
Morató A; Escabrós J; Manich A; Reig N; Castaño Y; Abián J; Messeguer A
Chem Res Toxicol; 2005 Apr; 18(4):665-74. PubMed ID: 15833026
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation and clearance of 3-(phenylamino)propane-1,2-diol, a compound present in samples related to toxic oil syndrome, in C57BL/6 and A/J mice.
Ladona MG; Bujons J; Messeguer A; Ampurdanés C; Morató A; Corbella J
Chem Res Toxicol; 1999 Dec; 12(12):1127-37. PubMed ID: 10604860
[TBL] [Abstract][Full Text] [Related]
4. Studies on toxic oil syndrome: stereoselective hydrolysis of 3-(phenylamino)propane-1,2-diol esters by human pancreatic lipase.
Morató A; Martínez-Cabot A; Escabrós J; Bujons J; Messeguer A
Chem Res Toxicol; 2004 Jul; 17(7):889-95. PubMed ID: 15257613
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and stability studies of the glutathione and N-acetylcysteine adducts of an iminoquinone reactive intermediate generated in the biotransformation of 3-(N-phenylamino)propane-1,2-diol: implications for toxic oil syndrome.
Martínez-Cabot A; Morató A; Messeguer A
Chem Res Toxicol; 2005 Nov; 18(11):1721-8. PubMed ID: 16300381
[TBL] [Abstract][Full Text] [Related]
6. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol.
Hill RH; Schurz HH; Posada de la Paz M; Abaitua Borda I; Philen RM; Kilbourne EM; Head SL; Bailey SL; Driskell WJ; Barr JR
Arch Environ Contam Toxicol; 1995 Feb; 28(2):259-64. PubMed ID: 7710294
[TBL] [Abstract][Full Text] [Related]
7. LC-MS ion maps for the characterization of aniline derivatives of fatty acids and triglycerides in laboratory-denatured rapeseed oil.
Reig N; Calaf RE; Messeguer A; Morató A; Escabros J; Gelpí E; Abian J
J Mass Spectrom; 2007 Apr; 42(4):527-41. PubMed ID: 17295417
[TBL] [Abstract][Full Text] [Related]
8. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic.
Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM
Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106
[TBL] [Abstract][Full Text] [Related]
9. Storage time and deodorization temperature influence the formation of aniline-derived compounds in denatured rapeseed oils.
Ruiz-Méndez MV; Posada de la Paz M; Abian J; Calaf RE; Blount B; Castro-Molero N; Philen R; Gelpí E
Food Chem Toxicol; 2001 Jan; 39(1):91-6. PubMed ID: 11259855
[TBL] [Abstract][Full Text] [Related]
10. Products of aniline and triglycerides in oil samples associated with the toxic oil syndrome.
Schurz HH; Hill RH; Posada de la Paz M; Philen RM; Borda IA; Bailey SL; Needham LL
Chem Res Toxicol; 1996 Sep; 9(6):1001-6. PubMed ID: 8870988
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome.
Posada de la Paz M; Philen RM; Schurz H; Hill RH; Giménez Ribota O; Gómez de la Camara A; Kilbourne EM; Abaitua I
Epidemiology; 1999 Mar; 10(2):130-4. PubMed ID: 10069247
[TBL] [Abstract][Full Text] [Related]
12. In vitro bioactivation of 3-(N-phenylamino)propane-1,2-diol by human and rat liver microsomes and recombinant P450 enzymes. Implications for toxic oil syndrome.
Martínez-Cabot A; Morató A; Commandeur JN; Vermeulen NP; Messeguer A
Chem Res Toxicol; 2007 Aug; 20(8):1218-24. PubMed ID: 17672514
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid anilides: in vivo formation and relevance to toxic oil syndrome.
Kaphalia BS; Khan MF; Ansari GA
J Biochem Mol Toxicol; 1999; 13(5):269-77. PubMed ID: 10402561
[TBL] [Abstract][Full Text] [Related]
14. Absorption and effects of 3-(N-phenylamino)-1,2-propanediol esters in relation to toxic oil syndrome.
Closa D; Folch E; Calaf RE; Abián J; Roselló-Catafau J; Gelpí E
Lipids; 2001 Oct; 36(10):1125-33. PubMed ID: 11768157
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
[TBL] [Abstract][Full Text] [Related]
17. Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: a potential link between eosinophilia-myalgia syndrome and toxic oil syndrome.
Martínez-Cabot A; Messeguer A
Chem Res Toxicol; 2007 Oct; 20(10):1556-62. PubMed ID: 17892268
[TBL] [Abstract][Full Text] [Related]
18. Determination of aniline derivatives in oils related to the toxic oil syndrome by atmospheric pressure ionization-tandem mass spectrometry.
Calaf RE; Peña J; Paytubi S; Blount BC; Posada de la Paz M; Gelpi E; Abian J
Anal Chem; 2001 Aug; 73(16):3828-37. PubMed ID: 11534704
[TBL] [Abstract][Full Text] [Related]
19. Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla.
Posada M; Castro M; Kilbourne EM; Diaz de Rojas F; Abaitua I; Tabuenca JM; Vioque A
Food Chem Toxicol; 1987 Jan; 25(1):87-90. PubMed ID: 3817664
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin and autoantibody responses in MRL/lpr mice treated with 'toxic oils'.
Koller LD; Stang BV; Hall JA; Posada de la Paz M; Ruiz Mendez MV
Toxicology; 2002 Sep; 178(2):119-33. PubMed ID: 12160619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
